COVID-19 trials registries data warehouse

 Return to trial list

Trial - EUCTR2020-001934-37-ES


Column Value
Trial registration number EUCTR2020-001934-37-ES
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

First author
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

IDIVAL - Mar García Sáiz

Contact
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

mmar.garcia@scsalud.es

Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

2020-05-08

Recruitment status
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Recruiting

Study design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

RCT

Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Randomized

Design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Parallel

Masking
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Open label

Center
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

multi-center

Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

- Patients admitted to hospital with Covid-19, confirmed by microbiological tests or compatible clinical manifestations, with exclusion of other infections. - Age: 18-85 years old. - Time of evolution: more than 7 days since the beginning of symptoms. - Evidence of inflammation, defined by: Lung infiltrates + Gas exchange disturbance: PaO2 < 65 or Sat<93% (breathing air), or PAFI <300, or SAFI <440, or BCRSS ≥2 + Elevated biomarkers: PCR >15, or DD>800, or Ferritin >1000, or IL6>20 - Absence of bacterial infection or other disease that explains the lung disorder. - Verbal informed consent, which will be recorded in history. - Pacientes ingresados en el hospital con Covid-19, confirmada mediante tests microbiológicos o cuadro clínico compatible, con exclusión de otras infecciones. - Edad: 18-85 años. - Tiempo de evolución: más de 7 días desde inicio de síntomas - Evidencia de inflamación, definida por: Infiltrados pulmonares + Alteración del intercambio gaseoso: PaO2 < 65 o Sat<93% (respirando aire), o PAFI <300, o SAFI <440, o BCRSS ≥2 + Biomarcadores elevados: PCR >15, o DD>800, o ferritina >1000, o IL6>20 - Ausencia de infección bacteriana u otra enfermedad que explique el trastorno pulmonar. - Consentimiento informado verbal, que se anotará en historia.

Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

- Refusal to participate - Pregnancy - Established indication for mechanical ventilation, non-invasive ventilation or ICU admission - Immunosuppression - Chronic renal failure on dialysis - Negativa a participar - Embarazo - Indicación establecida para ventilación mecánica, ventilación no invasiva o ingreso en UCI - Inmunosupresión - Insuficiencia renal crónica en diálisis

Number of arms
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

2

Funding
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

IDIVAL Instituto de Investigación Sanitaria Valdecilla

Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

18

Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

85

Countries
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Spain

Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

6: Severe disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

200

primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Combination of death, ICU stay or non-invasive ventilation (NIV). Combinación de muerte, estancia en UCI o Ventilación no invasiva (VNI).

Notes
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Declared number of arm (2.0) differs from found arms (1.0)

Phase
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

Phase 4

Arms
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register

[{"arm_notes": "", "treatment_id": 798, "treatment_name": "Methylprednisolone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]